Vystar Corp
Momentum & Growth

Vystar Corp (OTCMKTS:VYST) Explodes Higher On COVID-19 Opportunity

Vystar Corp (OTCMKTS:VYST) rallied by more than 100% on the confirmation it has resumed production of its Rx3000 hybrid ultraviolet UV-light air purification system. The big rally came on the backdrop of investors reacting to a perfect business opportunity amidst the COVID-19 pandemic that shows no signs of slowing down.

Vystar Corp Price Analysis

A 200% plus rally over the past one month attests to growing investors’ confidence about the company’s long term prospects, especially amidst the current COVID-19 pandemic. Vystar has emerged as one of the companies poised to be at the forefront in the fight against the deadly virus thanks to its array of products designed for use in healthcare facilities and hospitals.

Price action activity in the market has also picked pace as investors react to the huge opportunity up for grabs. Trading volume has already clocked highs of 132 million above the usual average of 3.5 million.

VYST Daily Chart

With the stock having turned bullish, be it in the short term, a rally to the $0.04 level appears to be on the cards. A rally followed by a close above the $0.05 level should re-affirm strength of the emerging uptrend, setting the stage for the stock to continue powering high. Similarly, the $0.02 level is the immediate support level, above which Vystar Corp remains well supported for further upside action.

What Does Vystar Corp Do?

Vystar Corp is a leading producer and distributor of Vytex natural rubber latex products used in the manufacture of rubber and rubber end products. Being the majority owner of Rotmans Furniture and Carpet, the company is also engaged in the development of friendly technologies and products for improving lives.

Covid-19 Air purifiers Opportunity

Vystar Corp is exploding in the market on the emergence of a perfect business opportunity around the havoc, causing Coronavirus. Investors are pushing the stock up the charts on the confirmation the company will start production works of its FDA approved RX3000 ultraviolet air purification system.

The system is the subject of increased demand in hospitals and healthcare facilities amidst the current coronavirus pandemic. The device is designed specifically for use in hospitals as well as healthcare facilities in purifying the air as it uses ultraviolet germicidal irradiation to in inactivate up to 99.97% of airborne viruses pathogens as well as bacteria.

“We are proud to say that we’ve resumed production of the RX3000 and it is now made in Worcester, Massachusetts, enabling more control over quality and distribution. We are now producing 50 units per week. Once we finish testing these units, we plan to ramp up to 1500 units,” stated Steve Rotmans, CEO of Vystar.

Market demand

The FDA is insisting on the use of ultraviolet germicidal irradiation in purification systems, given its proven ability to reduce the transmission of airborne bacterial and viral infections. The RX3000 is currently in use in hundreds of hospitals and healthcare facilities.

The fact that the air purification costs $800 a unit presents a unique opportunity for Vystar Corp to generate significant revenues on mass production. Vystar owns 100% of assets and patented intellectual property related to RX3000 for use in residential as well as small businesses.

In addition to the air purification system, Vystar Corp also remains well-positioned to benefit from strong demand for its high-quality natural rubber material. The materials are currently in high demand as they are being used to produce gloves in hospitals as well as healthcare facilities.

Likewise, the company remains well-positioned to benefit from a spike in demand for rubber gloves. The looming shortage for rubber is already causing rubber gloves makers to make big orders for the raw material to satisfy the strong demand in the market.

Bottom Line

Vystar Corp is staring at a perfect business opportunity triggered by the COVID-19 pandemic. The epidemic has already triggered a strong demand for air purifiers as healthcare professionals rush against time to control its spread. Likewise, there is strong demand for rubber products used in the production of gloves.

Backed by the RX3000 air purifiers and Vytex natural rubber, the company remains well-positioned to generate significant value amidst the challenging environment. Vystar stock looks set to continue edging higher as investors come to terms with the tremendous business opportunity at hand.

We will be updating our subscribers as soon as we know more. For the latest updates on OTCMKTS:VYST, sign up below!

Disclosure: We have no position in OTCMKTS:VYST and have not been compensated for this article.

GET NOTIFIED
Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
Vystar Corp (OTCMKTS:VYST) Explodes Higher On COVID-19 Opportunity
Click to comment
To Top